BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27307158)

  • 1. Hydroquinone-induced FOXP3-ADAM17-Lyn-Akt-p21 signaling axis promotes malignant progression of human leukemia U937 cells.
    Chen YJ; Liu WH; Chang LS
    Arch Toxicol; 2017 Feb; 91(2):983-997. PubMed ID: 27307158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Akt/Foxp3-mediated miR-183 expression blocks Sp1-mediated ADAM17 expression and TNFα-mediated NFκB activation in piceatannol-treated human leukemia U937 cells.
    Liu WH; Chang LS
    Biochem Pharmacol; 2012 Sep; 84(5):670-80. PubMed ID: 22705645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells.
    Chen YJ; Huang CH; Shi YJ; Lee YC; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2018 Nov; 358():43-55. PubMed ID: 30213730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound C induces autophagy and apoptosis in parental and hydroquinone-selected malignant leukemia cells through the ROS/p38 MAPK/AMPK/TET2/FOXP3 axis.
    Chiou JT; Huang CH; Lee YC; Wang LJ; Shi YJ; Chen YJ; Chang LS
    Cell Biol Toxicol; 2020 Aug; 36(4):315-331. PubMed ID: 31900833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroquinone-induced miR-122 down-regulation elicits ADAM17 up-regulation, leading to increased soluble TNF-α production in human leukemia cells with expressed Bcr/Abl.
    Chen YJ; Chang LS
    Biochem Pharmacol; 2013 Sep; 86(5):620-31. PubMed ID: 23791922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinacrine induces the apoptosis of human leukemia U937 cells through FOXP3/miR-183/β-TrCP/SP1 axis-mediated BAX upregulation.
    Huang CH; Lee YC; Chen YJ; Wang LJ; Shi YJ; Chang LS
    Toxicol Appl Pharmacol; 2017 Nov; 334():35-46. PubMed ID: 28867437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of ADAM17-mediated Lyn/Akt pathways induces apoptosis of human leukemia U937 cells: Bungarus multicinctus protease inhibitor-like protein-1 uncovers the cytotoxic mechanism.
    Liu WH; Chang LS
    J Biol Chem; 2010 Oct; 285(40):30506-15. PubMed ID: 20679348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzene metabolite hydroquinone induces apoptosis of bone marrow mononuclear cells through inhibition of β-catenin signaling.
    Li J; Jiang S; Chen Y; Ma R; Chen J; Qian S; Shi Y; Han Y; Zhang S; Yu K
    Toxicol In Vitro; 2018 Feb; 46():361-369. PubMed ID: 28886972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 MAPK/PP2Acα/TTP pathway on the connection of TNF-α and caspases activation on hydroquinone-induced apoptosis.
    Liu WH; Chou WM; Chang LS
    Carcinogenesis; 2013 Apr; 34(4):818-27. PubMed ID: 23288922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel signaling pathway associated with Lyn, PI 3-kinase and Akt supports the proliferation of myeloma cells.
    Iqbal MS; Tsuyama N; Obata M; Ishikawa H
    Biochem Biophys Res Commun; 2010 Feb; 392(3):415-20. PubMed ID: 20079716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway.
    Yang P; Dong F; Zhou Q
    Toxicol Lett; 2017 Aug; 278():9-17. PubMed ID: 28666825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.
    Chiou JT; Lee YC; Wang LJ; Chang LS
    Chem Biol Interact; 2022 Jul; 361():109978. PubMed ID: 35561756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells.
    Chen YJ; Wang JJ; Chang LS
    Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):755-63. PubMed ID: 21824174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
    Evans-Anderson HJ; Alfieri CM; Yutzey KE
    Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells.
    Chiou JT; Lee YC; Huang CH; Wang LJ; Shi YJ; Chang LS
    Biochem Pharmacol; 2021 Jun; 188():114544. PubMed ID: 33831396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
    Lee YC; Chen YJ; Huang CH; Chang LS
    Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroquinone-induced malignant transformation of TK6 cells by facilitating SIRT1-mediated p53 degradation and up-regulating KRAS.
    Chen Y; Chen J; Yun L; Xu L; Liu J; Xu Y; Yang H; Liang H; Tang H
    Toxicol Lett; 2016 Sep; 259():133-142. PubMed ID: 27515134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-α expression in hydroquinone-treated leukemia cells.
    Wang LJ; Lee YC; Chiou JT; Chen YJ; Chang LS
    Cell Biol Toxicol; 2023 Oct; 39(5):2207-2225. PubMed ID: 35302183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.